Symphony Holdings Limited Stock Predictions

Frankfurt Stock Exchange

Open Broker Account

0.0890€

+0 (+0%)

At Close: Aug 17, 2022

Currently predicting for Mon, 29 Apr 2024

YMP3.F Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Symphony Holdings Limited

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker	Date	Change	Price
DHT	Apr 24	2.04%	$11.28
MLI	Apr 19	9.66%	$52.28
LPLA	Apr 19	1.42%	$262.59
DOOR	Apr 18	0.167%	$131.39
LNG	Apr 17	1.49%	$156.81
FCN	Apr 16	1.80%	$207.62
ELV	Apr 16	5.97%	$506.97
AKR	Apr 05	4.78%	$16.53
ITCI	Apr 05	7.04%	$68.44
VSTS	Apr 04	0.425%	$18.82

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In